MedNews

  • Drug Industry News
  • FDA News & Alerts
  • Health & Medical News
You are here: Home / Health & Medical News / Menopause / Menopause Pill Pristiq Fails to Get FDA Approval

Menopause Pill Pristiq Fails to Get FDA Approval

July 29, 2007 By MedNews Leave a Comment

The Federal Drug Administration (FDA), in its letter to Wyeth—the manufacturer of the menopause Pill Pristiq—has outlined the need to perform at least one more year of clinical tests on the drug before it is aproved.

The FDA has called for more data on how Pristiq affects the heart and liver health of patients.
Wyeth, which is the largest manufacturer of hormone treatments today, has developed Pristiq to control menopausal symptoms such as night sweats and hot flashes and has forecast an annual revenue of $2 billion from the drug.

Filed Under: Menopause



Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search



Tag Cloud

alcohol alzheimers asthma breast cancer cancer children cholesterol dementia depression Diabetes diet drug abuse exercise fda flu food genetics geriatrics h1n1 heart heart attack heart disease high blood pressure HIV/AIDS hormone therapy hypertension lungs menopause mrsa NIH obesity pain pediatrics pregnancy prostate cancer seniors sleep smoking statistics stroke sun swine flu teens USA women's health

Recent Comments

  • Mia Fritz on Health Benefits of Dark Chocolate
  • Shilpa on Why Too Much Iron Can Be Dangerous
  • Racheal on Teen Pregnancy May Be Reduced by Sex Education in Schools, Says Study
  • Don on Prilosec, Nexium and Prevacid Tied to Higher Risk of Pneumonia
  • Meso on Brain Changes in Elderly Can Affect Mobility and Balance
  • About Us
  • Contact

Copyright © 2023 Mednews · Log in